The international BIOPROM 2025 Forum: Industry and Technologies for Humans was held in Gelendzhik on October 6-7. Discussing cutting-edge industrial technologies that affect human life quality is the goal of this important biotechnology industry event. Leading professionals and industry participants attended the forum, with the Pharmasyntez Group standing out as the event's general partner and taking part in its three main sessions.
Denis Manturov, First Deputy Prime Minister of the Russian Federation, Andrei Fursenko Presidential Aide, Inna Svyatenko, Deputy Chairman of the Federation Council, Irina Yarovaya, Deputy Chairman of the State Duma, and the heads of the Ministries of Industry and Trade, Agriculture, and Health attended the strategic session "Technologies for Life," which was the forum's main event. An Wenqi, General Director of Hualan Genetic Engineering Co., Ltd., represented the Pharmasyntez Group at the meeting and gave a report on the importance of international collaboration in the development of recombinant protein medications for worldwide healthcare.
The technological cooperation between the Russian pharmaceutical giant Pharmasyntez and the Chinese company Hualan Genetic is a vivid example of effective international partnership, contributing to the advancement of science and technology for the benefit of human health,
An Wenqi noted.
Two important agreements were signed within the forum's framework with the goal of promoting innovation and strengthening cooperation in the pharmaceutical industry.
The Chinese biotechnology company Hualan Bio and the Pharmasyntez Group signed a memorandum on strategic cooperation. In the area of cutting-edge medical technologies, the document is meant to be a significant step in the growth of scientific and technological cooperation between China and Russia.
A cooperation agreement on the localization of dialyzer production has been signed by SIBUR and Pharmasyntez-Medtech, a part of the Pharmasyntez Group. The development and scaling of production technologies for polycarbonate, polyethersulfone, and polysulfone—essential polymers for membrane fibers used in dialysis equipment—will be the focus of the joint work.
The BIOPROM 2025 Forum turned out to be a significant platform for sharing knowledge and creating fresh approaches to the development of the biotechnology sector. The Pharmasyntez Group's partnership attests to its leadership position and commitment to innovation for the benefit of public health.
